• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

韩国人中心脏脂肪变性状态下血红蛋白浓度与缺血性心脏病发病的纵向效应

Longitudinal Effect of Hemoglobin Concentration With Incident Ischemic Heart Disease According to Hepatic Steatosis Status Among Koreans.

作者信息

Jung Dong Hyuk, Lee Yong Jae, Park Byoungjin

机构信息

Department of Family Medicine, Yongin Severance Hospital, Yongin, South Korea.

Department of Family Medicine, Yonsei University College of Medicine, Seoul, South Korea.

出版信息

Front Cardiovasc Med. 2021 May 28;8:677040. doi: 10.3389/fcvm.2021.677040. eCollection 2021.

DOI:10.3389/fcvm.2021.677040
PMID:34124205
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8193037/
Abstract

An increased hemoglobin (Hb) level may have detrimental effects on hepatic steatosis (HS) as well as cardiovascular disease (CVD). We investigated Hb's effect on incident ischemic heart disease (IHD) risk in the context of hepatic steatosis (HS). We assessed 17,521 non-diabetic participants and retrospectively screened for IHD using the Korea National Health Insurance data. High Hb was defined as Hb levels ≥16.3 g/dL in men and 13.9 g/dL in women (>75th percentile). The participants were divided into five groups: reference (group 1), mild HS only (group 2), mild HS and high Hb (group 3), severe HS only (group 4), and severe HS and high Hb (group 5). We assessed hazard ratios (HRs) with 95% confidence intervals (CIs) for IHD using multivariate Cox proportional hazards regression models over 50 months from the baseline survey. During the follow-up period, 330 (1.9%) participants developed IHD (310 angina pectoris and 20 myocardial infarction). Compared with the reference group (group 1), the HRs for IHD were 1.04 (95% CI, 0.75-1.46) in group 2, 1.14 (95% CI, 0.70-1.85) in group 3, 1.58 (95% CI, 1.08-2.32) in group 4, and 1.79 (95% CI, 1.15-2.80) in group 5, after adjusting for IHD risk factors. We found the combined effect of HS and Hb levels on the incidence of IHD.

摘要

血红蛋白(Hb)水平升高可能对肝脂肪变性(HS)以及心血管疾病(CVD)产生有害影响。我们在肝脂肪变性(HS)的背景下研究了Hb对缺血性心脏病(IHD)发病风险的影响。我们评估了17521名非糖尿病参与者,并使用韩国国民健康保险数据对IHD进行回顾性筛查。高Hb定义为男性Hb水平≥16.3 g/dL,女性≥13.9 g/dL(>第75百分位数)。参与者被分为五组:参照组(第1组)、仅轻度HS组(第2组)、轻度HS和高Hb组(第3组)、仅重度HS组(第4组)以及重度HS和高Hb组(第5组)。我们使用多变量Cox比例风险回归模型,在基线调查后的50个月内评估IHD的风险比(HRs)及95%置信区间(CIs)。在随访期间,330名(1.9%)参与者发生了IHD(310例心绞痛和20例心肌梗死)。与参照组(第1组)相比,在调整IHD危险因素后,第2组IHD的HR为1.04(95%CI,0.75 - 1.46),第3组为1.14(95%CI,0.70 - 1.85),第4组为1.58(95%CI,1.08 - 2.32),第5组为1.79(95%CI,1.15 - 2.80)。我们发现了HS和Hb水平对IHD发病率的联合影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/918c/8193037/ba001a9eaf11/fcvm-08-677040-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/918c/8193037/16027525be01/fcvm-08-677040-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/918c/8193037/a2b619cb543c/fcvm-08-677040-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/918c/8193037/ba001a9eaf11/fcvm-08-677040-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/918c/8193037/16027525be01/fcvm-08-677040-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/918c/8193037/a2b619cb543c/fcvm-08-677040-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/918c/8193037/ba001a9eaf11/fcvm-08-677040-g0003.jpg

相似文献

1
Longitudinal Effect of Hemoglobin Concentration With Incident Ischemic Heart Disease According to Hepatic Steatosis Status Among Koreans.韩国人中心脏脂肪变性状态下血红蛋白浓度与缺血性心脏病发病的纵向效应
Front Cardiovasc Med. 2021 May 28;8:677040. doi: 10.3389/fcvm.2021.677040. eCollection 2021.
2
The Combination of Uric Acid and Hemoglobin Levels Predicts the Incident Risk of Ischemic Heart Disease More Than Uric Acid Alone in Non-Diabetic Koreans: A Longitudinal Study Using National Health Insurance Data.尿酸与血红蛋白水平联合预测非糖尿病韩国人缺血性心脏病发病风险优于单独尿酸:一项利用国民健康保险数据的纵向研究
J Pers Med. 2023 Dec 20;14(1):7. doi: 10.3390/jpm14010007.
3
Early Chronic Kidney Disease (G1-G3a) in Combination with Steatosis as a Predictor of Incident Ischemic Heart Disease: A Longitudinal Study in Non-Diabetic Koreans.早期慢性肾脏病(G1-G3a)合并脂肪变性作为缺血性心脏病发病的预测因素:一项针对非糖尿病韩国人的纵向研究。
Biomedicines. 2021 Sep 29;9(10):1358. doi: 10.3390/biomedicines9101358.
4
Joint Effect of Hepatic Steatosis and Alanine Aminotransferase Within the Normal Range on Incident Ischemic Heart Disease: A Prospective Study in Koreans.肝脂肪变和正常范围内的丙氨酸氨基转移酶联合对新发缺血性心脏病的影响:一项韩国前瞻性研究。
Clin Interv Aging. 2021 Mar 22;16:513-523. doi: 10.2147/CIA.S301741. eCollection 2021.
5
The triglyceride-glucose index predicts ischemic heart disease risk in Koreans: a prospective study using National Health Insurance Service data.甘油三酯-葡萄糖指数预测韩国人缺血性心脏病风险:基于国民健康保险服务数据的前瞻性研究。
Cardiovasc Diabetol. 2020 Dec 10;19(1):210. doi: 10.1186/s12933-020-01186-2.
6
Triglyceride to HDL-Cholesterol Ratio and the Incident Risk of Ischemic Heart Disease Among Koreans Without Diabetes: A Longitudinal Study Using National Health Insurance Data.甘油三酯与高密度脂蛋白胆固醇比值及无糖尿病韩国人缺血性心脏病发病风险:一项利用国民健康保险数据的纵向研究
Front Cardiovasc Med. 2021 Aug 17;8:716698. doi: 10.3389/fcvm.2021.716698. eCollection 2021.
7
Predictive Value of the Atherogenic Index of Plasma (AIP) for the Risk of Incident Ischemic Heart Disease among Non-Diabetic Koreans.血浆致动脉粥样硬化指数(AIP)对非糖尿病韩国人群新发缺血性心脏病风险的预测价值。
Nutrients. 2021 Sep 16;13(9):3231. doi: 10.3390/nu13093231.
8
Elevated Uric Acid Levels with Early Chronic Kidney Disease as an Indicator of New-Onset Ischemic Heart Disease: A Cohort of Koreans without Diabetes.以早期慢性肾脏病高尿酸水平作为新发缺血性心脏病指标:一项针对无糖尿病韩国人群的队列研究
Biomedicines. 2023 Aug 7;11(8):2212. doi: 10.3390/biomedicines11082212.
9
Potential Association of Isolated γ-Glutamyltransferase Elevation with Incident Ischemic Heart Disease in Lean Koreans.韩国瘦人群体中孤立性γ-谷氨酰转移酶升高与缺血性心脏病发病之间的潜在关联
J Pers Med. 2022 Nov 28;12(12):1966. doi: 10.3390/jpm12121966.
10
The Metabolic Score for Insulin Resistance (METS-IR) as a Predictor of Incident Ischemic Heart Disease: A Longitudinal Study among Korean without Diabetes.胰岛素抵抗代谢评分(METS-IR)作为缺血性心脏病发病的预测指标:一项针对无糖尿病韩国人的纵向研究。
J Pers Med. 2021 Jul 28;11(8):742. doi: 10.3390/jpm11080742.

引用本文的文献

1
Combined effect of serum carcinoembryonic antigen and hepatic steatosis on new-onset ischemic heart disease among middle-aged and older Korean adults: a cohort study.血清癌胚抗原与肝脂肪变性对韩国中老年成年人新发缺血性心脏病的联合影响:一项队列研究
Front Nutr. 2023 Oct 10;10:1275450. doi: 10.3389/fnut.2023.1275450. eCollection 2023.
2
Potential Association of Isolated γ-Glutamyltransferase Elevation with Incident Ischemic Heart Disease in Lean Koreans.韩国瘦人群体中孤立性γ-谷氨酰转移酶升高与缺血性心脏病发病之间的潜在关联
J Pers Med. 2022 Nov 28;12(12):1966. doi: 10.3390/jpm12121966.
3
Triglyceride to HDL-Cholesterol Ratio and the Incident Risk of Ischemic Heart Disease Among Koreans Without Diabetes: A Longitudinal Study Using National Health Insurance Data.

本文引用的文献

1
NAFLD and Atherosclerosis: Two Sides of the Same Dysmetabolic Coin?非酒精性脂肪性肝病与动脉粥样硬化:同一代谢紊乱之两面?
Trends Endocrinol Metab. 2019 Dec;30(12):891-902. doi: 10.1016/j.tem.2019.08.008. Epub 2019 Oct 17.
2
Leg electrical resistance predicts venous blood viscosity and hematocrit.腿部电阻预测静脉血液黏度和血细胞比容。
Clin Hemorheol Microcirc. 2019;71(4):397-402. doi: 10.3233/CH-199003.
3
Serum ferritin, an early marker of cardiovascular risk: a study in Chinese men of first-degree relatives with family history of type 2 diabetes.
甘油三酯与高密度脂蛋白胆固醇比值及无糖尿病韩国人缺血性心脏病发病风险:一项利用国民健康保险数据的纵向研究
Front Cardiovasc Med. 2021 Aug 17;8:716698. doi: 10.3389/fcvm.2021.716698. eCollection 2021.
血清铁蛋白,心血管风险的早期标志物:一项在有 2 型糖尿病家族史一级亲属的中国男性中进行的研究。
BMC Cardiovasc Disord. 2019 Apr 3;19(1):82. doi: 10.1186/s12872-019-1068-5.
4
Iron and liver fibrosis: Mechanistic and clinical aspects.铁与肝纤维化:机制与临床方面。
World J Gastroenterol. 2019 Feb 7;25(5):521-538. doi: 10.3748/wjg.v25.i5.521.
5
Association between non-alcoholic fatty liver disease and risk of atrial fibrillation in adult individuals: An updated meta-analysis.非酒精性脂肪性肝病与成人心房颤动风险的相关性:一项更新的荟萃分析。
Liver Int. 2019 Apr;39(4):758-769. doi: 10.1111/liv.14044. Epub 2019 Feb 7.
6
Mechanisms of NAFLD development and therapeutic strategies.非酒精性脂肪性肝病发病机制及治疗策略。
Nat Med. 2018 Jul;24(7):908-922. doi: 10.1038/s41591-018-0104-9. Epub 2018 Jul 2.
7
Liver fat imaging-a clinical overview of ultrasound, CT, and MR imaging.肝脏脂肪成像——超声、CT和磁共振成像的临床概述
Br J Radiol. 2018 Sep;91(1089):20170959. doi: 10.1259/bjr.20170959. Epub 2018 Jun 6.
8
Risk of cardiomyopathy and cardiac arrhythmias in patients with nonalcoholic fatty liver disease.非酒精性脂肪性肝病患者的心肌病和心律失常风险。
Nat Rev Gastroenterol Hepatol. 2018 Jul;15(7):425-439. doi: 10.1038/s41575-018-0010-0.
9
The influence of NAFLD on the risk of atherosclerosis and cardiovascular diseases.非酒精性脂肪性肝病对动脉粥样硬化和心血管疾病风险的影响。
Clin Exp Hepatol. 2018 Mar;4(1):1-6. doi: 10.5114/ceh.2018.73155. Epub 2018 Jan 20.
10
Hemoglobin, Albuminuria, and Kidney Function in Cardiovascular Risk: The ARIC (Atherosclerosis Risk in Communities) Study.血红蛋白、白蛋白尿与心血管风险中的肾功能:ARIC(社区动脉粥样硬化风险)研究。
J Am Heart Assoc. 2018 Jan 12;7(2):e007209. doi: 10.1161/JAHA.117.007209.